An interventional study of Mindfulness and Counseling in Somatosensory Tinnitus, sponsored by Universidade Federal de Santa Maria. Recruiting at 1 site in Brazil. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-17.
Sponsored by Universidade Federal de Santa Maria · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 21 studies in Tinnitus with a site in Brazil — 2 open to participants now, 3 under way, none of them phase 3. Tinnitus · Brazil.
Among the 21 studies in Tinnitus with a site in Brazil, this one is the 9th largest by planned enrollment of the 17 interventional ones that give a count, is the only one that started in 2025, is one of 11 with no phase, and was the 21st registered.
444 studies on the registry are indexed under Tinnitus; 98 are open to participants now.
Browse Tinnitus studies →2 of the 21 studies in Tinnitus with a site in Brazil are open now. Recruiting first, the newest first:
Universidade Federal de Santa Maria · Sites in Brazil
Ages 18–55
A study can be open while its sites in Brazil have not opened yet or have stopped. Only those recruiting at a site in Brazil →
Of the 49 Tinnitus studies recruiting now, 21 (43%) set no upper age limit and 18 (37%) stop at 75 or younger; 4 take children under 18; 11 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
21 studies; the count open now beside each. This study's row is marked.
First in 2006; this study’s year is marked. 1 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 52 is below the median of 60 across 368 interventional studies indexed under Tinnitus.
Median enrollment 52 across the 17 interventional studies, 100 across the 4 observational. Of the 13 that completed or were terminated, 1 (8%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 21 have an industry lead sponsor. The 8 most frequent:
Universidade Federal de Santa Maria is the lead sponsor of 38 studies on the registry; 3 are open to participants now.
Universidade Federal de Santa Maria has 2 studies filed under Tinnitus — fewer than ten, so there is no comparison to draw.
1 of the studies in Tinnitus with a site in Brazil that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07941648Universidade Federal de Santa MariaCombined Treatments for Somatosensory Tinnitus | 2027-06 |
Add it to your calendar (.ics) → With an account.
Among the 21 studies in Tinnitus with a site in Brazil, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this clinical trial is to evaluate whether a combination of manual therapies, therapeutic exercises, and integrative and complementary practices reduces the loudness, discomfort, and impact of somatosensory tinnitus. This type of tinnitus is associated with changes in the neck and/or jaw joint.
The main questions this study aims to answer are:
Does the combined treatment reduce tinnitus loudness, discomfort, and impact more than placebo?
Are the benefits maintained three months after treatment ends?
Researchers will compare two groups: one will receive the combined treatment targeting the neck and jaw regions, and the other will receive simulated procedures (placebo) that resemble the treatment procedures.
Participants will:
Attend one session per week for 12 weeks (three months), receiving either the combined treatment or placebo, depending on the group to which they are randomly assigned.
Complete questionnaires before and at the end of the 12 weeks.
Return for a follow-up assessment three months after the sessions end to determine whether the effects have been maintained.
Somatosensory tinnitus is a form of tinnitus in which sensory input from the neck or jaw can influence the perceived sound. In some individuals, tinnitus changes during neck or jaw movements or in response to pressure on specific muscles. The clinical rationale for this trial is to address these musculoskeletal factors alongside the burden of tinnitus in daily life.
The treatment program combines manual therapies, therapeutic exercise, and integrative and complementary practices. These approaches were selected to address different aspects of the condition within the same program, including muscle tension, movement and function of the neck and jaw, and how participants respond to tinnitus. The study hypothesis is that these complementary approaches may provide greater benefit when delivered as a combined program than the simulated procedures used as the placebo control.
This placebo-controlled clinical trial will compare the effects of the combined program and the simulated procedures in adults with somatosensory tinnitus. The study will evaluate changes in perceived tinnitus loudness, tinnitus-related bothersomeness, and the impact of tinnitus on daily life. Follow-up will assess whether any improvements observed at the end of treatment are maintained.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Fibromyalgia;
Previous negative experiences with needles used for therapeutic purposes;
A formal to dry needling, such as chronic anticoagulant use or hematological disorders;
Altered sensation.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will receive 12 weekly sessions over three months. During the first month, treatment will combine mindfulness and myofascial release. During the second month, treatment will combine mindfulness and Pilates exercises. During the third month, treatment will combine auriculotherapy and dry needling. The physical interventions will target the cervical and temporomandibular regions.
Behavioral: Mindfulness · Behavioral: Counseling · Procedure: Myofascial release · Procedure: Pilates · Procedure: Auriculotherapy · Procedure: Dry Needling
Participants will receive 12 weekly sessions over three months. During the first month, they will listen to relaxation recordings matched in duration to the mindfulness practices in the intervention group and receive manual manipulation without trigger point deactivation techniques. During the second month, they will listen to the same types of recordings and perform gentle, unloaded movements, including upper limb, lower limb, and spinal stretching. During the third month, they will receive microporous adhesive tape applied to the ear without stimulation of auricular points and superficial skin needling in the abdominal, quadriceps, and gastrocnemius regions.
Behavioral: Relaxation Audio Recordings · Procedure: Manual Manipulation Without Trigger Point Deactivation · Procedure: Gentle Movements and Stretching · Procedure: Auricular Tape Application Without Stimulation · Procedure: Superficial Skin Needling
This intervention is part of the G1 intervention group and consists of seven sessions using guided mindfulness recordings. Participants will be instructed to practice once daily. The recordings will be replaced weekly and sent via WhatsApp. Each recording lasts between 3 and 15 minutes.
Counseling is part of the G1 intervention and will be delivered individually during the first session, lasting 15 minutes. Guidance will be tailored to each participant's needs to encourage adherence to the proposed practices and changes in behaviors and lifestyle habits that may contribute to worsening tinnitus.
Myofascial release is part of the G1 intervention and will be delivered in four sessions. Myofascial trigger points will be treated using gradually increasing, sustained digital pressure until the participant reports no tenderness at the site, followed by manual techniques along the taut muscle band. Target muscles will include the infraspinatus, levator scapulae, upper trapezius, splenius capitis, splenius cervicis, sternal head of the sternocleidomastoid, superficial masseter, anterior temporalis, and lateral and medial pterygoids. Myofascial release will last 30 minutes during the first session, which will also include counseling and an introduction to mindfulness. Each of the remaining three sessions will include 40 minutes of myofascial release.
Pilates is part of the G1 intervention and will be delivered during the second month of treatment, comprising four weekly 40 minutes sessions at the tinnitus outpatient clinic. Mat-based exercises will use a mat, a small exercise ball, and 1-kg dumbbells, with adaptations for individuals with tinnitus, neck pain, and muscle tension. Each exercise will be performed in one set of 10, 15, or 20 repetitions, adjusted to the participant's fitness level and reported pain and fatigue. Sessions will include preparatory pre-Pilates and breathing exercises, basic exercises incorporating Pilates principles, and final stretching. Participants with temporomandibular disorders will also receive specific temporomandibular joint exercises and instructions to perform them at home once daily until the end of treatment.
Auriculotherapy is part of the G1 intervention and will be delivered during the third month of treatment in four weekly 10-minute sessions. Auricular points will be selected based on Traditional Chinese Medicine and previous studies addressing tinnitus and muscle tension in the cervical, thoracic, and temporomandibular regions. Mustard seeds will be secured to the ear with microporous adhesive tape, alternating between the right and left ears each week. Participants will be instructed to keep the seeds in place for up to three days and press each auricular point 15 times, at least three times daily.
Dry needling is part of the G1 intervention and will be delivered during the third month of treatment in four weekly sessions alongside auriculotherapy. Sterile, single-use, disposable acupuncture needles measuring 0.20 × 30 mm (DUX) will be used. The therapist will wear gloves, and the skin will be disinfected with 70% w/w alcohol. Participants will be positioned supine for needling of the upper trapezius, sternocleidomastoid, masseter, and lateral pterygoid; prone for the upper trapezius and infraspinatus; and side-lying for the splenius capitis, splenius cervicis, and levator scapulae.
This intervention is part of the G2 control group and consists of listening to relaxation recordings selected from YouTube during the first and second months of treatment. The recordings will be matched in duration to the mindfulness practices used in the G1 intervention group. Participants will be instructed to listen once daily. The recordings will be replaced weekly and sent via WhatsApp.
This intervention is part of the G2 control group and will be delivered during the first month of treatment in four weekly sessions. Participants will receive manual manipulation without myofascial trigger point deactivation techniques. Session duration will match that of myofascial release in G1: 30 minutes in the first session and 40 minutes in each of the remaining three sessions.
This intervention is part of the G2 control group and will be delivered during the second month of treatment in four weekly 40 minutes sessions. Participants will perform gentle, unloaded movements, including upper limb, lower limb, and spinal stretching, as a comparison intervention to the Pilates exercises performed by the G1 group.
This intervention is part of the G2 control group and will be delivered during the third month of treatment in four weekly sessions. Microporous adhesive tape will be applied to the ear without seeds or stimulation of auricular points, as a sham comparison to auriculotherapy in the G1 group.
This intervention is part of the G2 control group and will be delivered during the third month of treatment in four weekly sessions, alongside auricular tape application without stimulation. Participants will receive superficial skin needling in the abdominal, quadriceps, and gastrocnemius regions as a comparison procedure to dry needling in the G1 group.
Change in Tinnitus Discomfort Visual Analog Scale Score
Tinnitus-related discomfort will be assessed using a visual analog scale (VAS) ranging from 0 to 10. Higher scores indicate greater discomfort. A decrease in score from baseline indicates improvement.
Time frame: Baseline, immediately after completion of the 12-week treatment, and three months after treatment completion.
Change in Tinnitus Loudness Visual Analog Scale Score
Perceived tinnitus loudness will be rated on a visual analog scale ranging from 0 to 10. Higher scores indicate greater perceived loudness. A reduction from baseline indicates improvement.
Time frame: Baseline, immediately after completion of the 12-week treatment, and three months after treatment completion.
Change in Tinnitus Handicap Inventory Total Score
Handicap Inventory Total Score The 25-item Tinnitus Handicap Inventory will assess tinnitus-related handicap. Total scores range from 0 to 100, with higher scores indicating greater handicap. A reduction from baseline indicates improvement.
Time frame: Baseline, immediately after completion of the 12-week treatment, and three months after treatment completion.
Change in Tinnitus Functional Index Total Score
The 25-item Tinnitus Functional Index will assess tinnitus severity and functional impact. Total scores range from 0 to 100, with higher scores indicating greater impact. A reduction from baseline indicates improvement.
Time frame: Baseline, immediately after completion of the 12-week treatment, and three months after treatment completion.
Change in Hospital Anxiety and Depression Scale Anxiety and Depression Subscale Scores
Anxiety and depressive symptoms will be assessed using the Hospital Anxiety and Depression Scale (HADS), a 14-item questionnaire comprising two seven-item subscales. Each subscale ranges from 0 to 21, with higher scores indicating more severe symptoms. Changes from baseline will be assessed separately for anxiety and depression.
Time frame: Baseline, immediately after completion of the 12-week treatment, and three months after treatment completion.
Change in Neck Disability Index Total Score
Neck-related disability will be assessed using the 10-item Neck Disability Index. Raw total scores range from 0 to 50, with higher scores indicating greater disability. A reduction from baseline indicates improvement.
Time frame: Baseline, immediately after completion of the 12-week treatment, and three months after treatment completion.
Change in Maximum Skin Temperature Assessed by Infrared Thermography
Maximum skin temperature, in degrees Celsius (°C), will be assessed using infrared thermography over the surface regions corresponding to the infraspinatus, levator scapulae, upper trapezius, splenius capitis, splenius cervicis, sternal head of the sternocleidomastoid, superficial masseter, and anterior temporalis. Images will be acquired with participants standing, using anterior, posterior, and lateral views to evaluate temperature changes following treatment.
Time frame: Baseline, immediately after completion of the 12-week treatment, and three months after treatment completion.
Plan to share: Undecided — A decision regarding the sharing of individual participant data has not yet been made. The research team will evaluate the feasibility and conditions for data sharing.
Started Jan 2025 (actual). Primary completion is estimated for Jun 2027, 29 months after the start.
Of 133 non-industry interventional studies with no phase under Tinnitus, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 38. This study's planned 29 months is above that.
Counting every sponsor, half of 151 studies reached it within 17 months; a quarter within 10 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universidade Federal de Santa Maria